taltz

Generic: ixekizumab

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name taltz
Generic Name ixekizumab
Labeler eli lilly and company
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

ixekizumab 40 mg/.5mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-8905
Product ID 0002-8905_246fceb3-0f60-4bd7-8f06-4f34537f5d95
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125521
Listing Expiration 2026-12-31
Marketing Start 2016-03-22

Pharmacologic Class

Established (EPC)
interleukin-17a antagonist [epc]
Mechanism of Action
interleukin-17a antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00028905
Hyphenated Format 0002-8905

Supplemental Identifiers

RxCUI
1745103 1745108 1745112 1745114 2674931 2674932 2674933 2674934
UNII
BTY153760O
NUI
N0000191495 N0000191494

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name taltz (source: ndc)
Generic Name ixekizumab (source: ndc)
Application Number BLA125521 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 40 mg/.5mL
source: ndc
Packaging
  • 1 SYRINGE in 1 CARTON (0002-8905-11) / 1 mL in 1 SYRINGE (0002-8905-01)
source: ndc

Packages (1)

0002-8905-11 1 SYRINGE in 1 CARTON (0002-8905-11) / 1 mL in 1 SYRINGE (0002-8905-01)

Ingredients (1)

ixekizumab (40 mg/.5mL)

Linked Drug Pages (1)

TALTZ ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "246fceb3-0f60-4bd7-8f06-4f34537f5d95", "openfda": {"nui": ["N0000191495", "N0000191494"], "unii": ["BTY153760O"], "rxcui": ["1745103", "1745108", "1745112", "1745114", "2674931", "2674932", "2674933", "2674934"], "spl_set_id": ["ac96658a-d7dc-4c7c-8928-2adcdf4318b2"], "pharm_class_epc": ["Interleukin-17A Antagonist [EPC]"], "pharm_class_moa": ["Interleukin-17A Antagonists [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (0002-8905-11)  / 1 mL in 1 SYRINGE (0002-8905-01)", "package_ndc": "0002-8905-11", "marketing_start_date": "20240202"}], "brand_name": "TALTZ", "product_id": "0002-8905_246fceb3-0f60-4bd7-8f06-4f34537f5d95", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Interleukin-17A Antagonist [EPC]", "Interleukin-17A Antagonists [MoA]"], "product_ndc": "0002-8905", "generic_name": "ixekizumab", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TALTZ", "active_ingredients": [{"name": "IXEKIZUMAB", "strength": "40 mg/.5mL"}], "application_number": "BLA125521", "marketing_category": "BLA", "marketing_start_date": "20160322", "listing_expiration_date": "20261231"}